Biostage, Inc. (BSTG) financial statements (2020 and earlier)

Company profile

Business Address 84 OCTOBER HILL ROAD
HOLLISTON, MA 01746
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments11437514
Cash and cash equivalents11437514
Restricted cash and investments 0     
Receivables  00000
Inventory, net of allowances, customer advances and progress billings    000
Inventory    000
Prepaid expense 000 00
Other current assets 000   
Other undisclosed current assets00(0) 00 
Total current assets:22438614
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment0011111
Total noncurrent assets:1011111
TOTAL ASSETS:23559715
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:0011000
Accounts payable0011000
Accrued liabilities 0     
Other undisclosed accounts payable and accrued liabilities 0     
Debt0      
Derivative instruments and hedges, liabilities0001   
Due to related parties  0  00
Other undisclosed current liabilities0001000
Total current liabilities:1123110
Noncurrent Liabilities
Long-term debt and lease obligation0      
Operating lease, liability0
Total noncurrent liabilities:0      
Total liabilities:1123110
Stockholders' equity
Stockholders' equity attributable to parent, including:12328615
Common stock0000000
Additional paid in capital64585038331916
Accumulated other comprehensive income (loss)    (0)0 
Accumulated deficit(62)(56)(48)(36)(25)(13)(2)
Other undisclosed stockholders' equity attributable to parent  1    
Total stockholders' equity:12328615
TOTAL LIABILITIES AND EQUITY:23559715

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues   0000
Cost of revenue   (0)(0)(0)(0)
Gross profit:   (0)(0)00
Operating expenses(9)(8)(11)(12)(12)(11)(9)
Operating loss:(9)(8)(11)(12)(12)(11)(9)
Nonoperating income (expense)10(0)1(0)(0) 
Other nonoperating income (expense) (0)(0)1   
Interest and debt expense   (0)   
Other undisclosed income from continuing operations before equity method investments, income taxes   0   
Net loss available to common stockholders, diluted:(9)(8)(12)(12)(12)(11)(9)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(9)(8)(12)(12)(12)(11)(9)
Other comprehensive income (loss)   0(0)(0) 
Comprehensive loss:(9)(8)(12)(12)(12)(11)(9)
Other undisclosed comprehensive income, net of tax, attributable to parent     0 
Comprehensive loss, net of tax, attributable to parent:(9)(8)(12)(12)(12)(11)(9)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: